|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for loan losses | |||||
| Gains on sales of securities available for sale, net | |||||
| Loss on disposal of assets, net | |||||
| Goodwill impairment | |||||
| Originations of mortgage loans held for sale | |||||
| Proceeds from sales of mortgage loans held for sale | |||||
| (Gains) losses on sales of mortgage loans held for sale, net | |||||
| Premium amortization on securities, net | |||||
| Deferred income tax expense | |||||
| Gain on sale of majority interest in consolidated subsidiary | |||||
| Share-based compensation | |||||
| (Gains) losses on sales of other real estate owned, net | |||||
| Valuation adjustments on other real estate owned | |||||
| Valuation adjustments on other assets held for sale | |||||
| Decrease in prepaid FDIC insurance | |||||
| Increase in bank owned life insurance cash surrender value | |||||
| Changes in assets and liabilities: | |||||
| Increase in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Proceeds from maturity, calls, principal repayments and sales of securities available for sale | |||||
| Proceeds from maturity, calls, and principal repayments of held to maturity | |||||
| Purchases of securities held to maturity | |||||
| Purchases of securities available for sale | |||||
| (Purchases) redemptions of restricted stock, net | |||||
| (Purchases) sales of bank premises and equipment, net | |||||
| Loan originations, net | |||||
| Proceeds from sales of loans | |||||
| Purchases of loans | |||||
| Proceeds from sale of majority interest in consolidated subsidiary, net | |||||
| Proceeds from sale of other real estate owned and repossessed assets | |||||
| Purchase of bank-owned life insurance | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Increase in demand, interest-bearing demand and savings deposits | |||||
| Decrease in certificates of deposit | |||||
| Increase (decrease) in securities sold under agreements to repurchase | |||||
| Decrease in short-term borrowings | |||||
| Distributions to non-controlling interest | |||||
| Increase (decrease) in FHLB borrowings | |||||
| Payment of dividends on common stock | |||||
| Proceeds from exercise of options and warrant | |||||
| Excess tax benefit on share-based compensation | |||||
| Repurchases of common stock | |||||
| Net cash provided by (used in) provided by financing activities | |||||
| Decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Disclosures of Cash Flow Information | |||||
| Interest paid | |||||
| Income taxes | |||||
| Supplemental Disclosure of Non-Cash Transactions | |||||
| Unrealized gains (losses) on securities available for sale | |||||
| Change in market value of interest rate swaps | |||||
| Transfer of loans to other real estate owned and repossessed assets | |||||
| Loans originated for sale of other real estate owned | |||||
| Transfer of other real estate owned to premises and equipment | |||||
Loading...